Aging
Featured Topics
Lead story
Other featured articles
-
Immune Cells Are Associated with Mortality: the Health and Retirement Study
The research findings support the idea that an aging immune system is associated with short-term mortality independent of age-related inflammation or other age-related measures of physiological dysfunction.
Posted in -
Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease
Differential eligibility may contribute to underrepresentation of some minoritized racial and ethnic groups in early AD trials. Amyloid biomarker eligibility is a requirement to confirm the diagnosis of AD and for treatment with amyloid-lowering drugs and differed among racial and ethnic groups.
Posted in -
Epidemiology of Mortality Attributed to Falls in Older Adults in the US, 1999–2020
The age-adjusted mortality rate (AAMR) of falls among adults aged 65 years or older rose nationally from 29.4 to 69.4 per 100,000 from 1999 to 2020.
Posted in -
Podcast: Jack Chapel on Health Trends in a Shrinking Middle Class
Health Affairs Editor-in-Chief Alan Weil interviews Jack Chapel, a PhD candidate in economics at the USC Dornsife College of Letters, Arts and Sciences, about a new study examining the worsening health and economic trends for Americans with modest resources nearing retirement.
Posted in
About this section
People are living longer, which brings obvious benefits as well as considerable challenges — from Alzheimer’s and other age-related diseases to increased injuries, disabilities and poverty risks. Policymakers around the world rely on Schaeffer Center research and modeling tools for finding ways to help keep people as healthy as possible throughout their lives.
Our Experts On Aging
Our Work In Aging
-
Estimates of Diagnosed Dementia Prevalence and Incidence Among Diverse Beneficiaries in Traditional Medicare and Medicare Advantage
The prevalence of diagnosed dementia among beneficiaries in MA was lower than in TM.
-
The Forgotten Middle: Worsening Health And Economic Trends Extend To Americans With Modest Resources Nearing Retirement
Researchers at the USC Schaeffer Center analyzed the health and economic well-being of Americans in their mid-fifties between 1994 and 2018 and found disparities between lower-middle income and upper-middle income households widened substantially. Dubbed the forgotten middle, lower-middle income Americans nearing retirement are no better off in terms of health or economic well-being than their counterparts two decades ago.
Categorized in -
Lower-Middle Class Americans Near Retirement are Worse Off Than 20 Years Ago, New USC and Columbia Study ShowsÂ
‘Forgotten middle’ Americans face poorer health, worse economic outcomes and lower homeownership rates, along with increased disability in old age.
Categorized in -
Alzheimer’s Drug Approved; USC Policy Experts Available to Discuss FDA Approval of Leqembi
For the first time in two decades, an Alzheimer’s drug has received full Food and Drug Administration (FDA) approval. USC Schaeffer Center experts are available to discuss this milestone and the challenges ahead.
Categorized in -
Without Early Detection, Fighting Dementia Is an Uphill Battle
A brief assessment in primary care can help identify patients most at risk
Categorized in -
Blood Pressure Medication and Dementia Prevention: The Promising Link
SC Schaeffer Center researchers have turned to real-world data to probe the relationship between antihypertensive use and dementia risk in the U.S. population and among minoritized populations who are at the highest risk of dementia.
Categorized in